Literature DB >> 16505579

Metabolic syndrome.

Atul Gogia1, P K Agarwal.   

Abstract

The Metabolic syndrome is a widely prevalent and multi-factorial disorder. The syndrome has been given several names, including- the metabolic syndrome, the insulin resistance syndrome, the plurimetabolic syndrome, and the deadly quartet. With the formulation of NCEP/ATP III guidelines, some uniformity and standardization has occurred in the definition of metabolic syndrome and has been very useful for epidemiological purposes. The mechanisms underlying the metabolic syndrome are not fully known; however resistance to insulin stimulated glucose uptake seems to modify biochemical responses in a way that predisposes to metabolic risk factors. The clinical relevance of the metabolic syndrome is related to its role in the development of cardiovascular disease. Management of the metabolic syndrome involves patient-education and intervention at various levels. Weight reduction is one of the main stays of treatment. In this article we comprehensively discuss this syndrome- the epidemiology, pathogenesis, clinical relevance and management. The need to do a comprehensive review of this particular syndrome has arisen in view of the ever increasing incidence of this entity. Soon, metabolic syndrome will overtake cigarette smoking as the number one risk factor for heart disease among the US population. Hardly any issue of any primary care medical journal can be opened without encountering an article on type 2 diabetes, dyslipidemia or hypertension. It is rare to see type 2 diabetes, dyslipidemia, obesity or hypertension in isolation. Insulin resistance and resulting hyperinsulinemia have been implicated in the development of glucose intolerance (and progression to type 2 diabetes), hypertriglyceridemia, hypertension, polycystic ovary syndrome, hypercoagulability and vascular inflammation, as well as the eventual development of atherosclerotic cardiovascular disease manifested as myocardial infarction, stroke and myriad end organ diseases. Conversely, treatment and consequent improvement of insulin resistance have been shown to result in better outcomes in virtually all of these conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505579

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  11 in total

1.  The association of the metabolic syndrome with QTc interval in NHANES III.

Authors:  Mohammed F Faramawi; Rachel P Wildman; Jeanette Gustat; Janet Rice; Mohammed Y Abdul Kareem
Journal:  Eur J Epidemiol       Date:  2008-05-29       Impact factor: 8.082

2.  Association between components of metabolic syndrome and prostatic enlargement: An Indian perspective.

Authors:  P R Nandy; Sabyasachi Saha
Journal:  Med J Armed Forces India       Date:  2016-09-05

Review 3.  Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome.

Authors:  Areli Carrera-Lanestosa; Yolanda Moguel-Ordóñez; Maira Segura-Campos
Journal:  J Med Food       Date:  2017-08-09       Impact factor: 2.786

4.  Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.

Authors:  Christiaan J Masson; Jogchum Plat; Ronald P Mensink; Andrzej Namiot; Wojciech Kisielewski; Zbigniew Namiot; Joachim Füllekrug; Robert Ehehalt; Jan F C Glatz; Maurice M A L Pelsers
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

5.  Metabolic syndrome and periodontal disease.

Authors:  Vipin Bharti; Pankaj Khurana
Journal:  J Indian Soc Periodontol       Date:  2009-09

Review 6.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

Review 7.  Dietary restriction and brain health.

Authors:  Guang Qiu; Shan Liu; Kwok-Fai So
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

8.  Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case -control study.

Authors:  Toba Kazemi; Gholamreza Sharifzadeh; Asghar Zarban; Azita Fesharakinia
Journal:  Int J Prev Med       Date:  2013-01

9.  Metabolic syndrome and other cardiovascular risk factors among police officers.

Authors:  Jayakrishnan Thayyil; Thejus Thayyil Jayakrishnan; Meharoof Raja; Jeeja Mathumal Cherumanalil
Journal:  N Am J Med Sci       Date:  2012-12

10.  Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.

Authors:  Ali Cyrus; Ali Kabir; Davood Goodarzi; Afsaneh Talaei; Ali Moradi; Mohammad Rafiee; Mehrdad Moghimi; Elham Shahbazi; Elaheh Farmani
Journal:  Korean J Urol       Date:  2014-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.